Expertise in
13
conditions

Troels Herlin

Vennelyst Blvd. 9, 
Aarhus C, DK 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
13
conditions
Vennelyst Blvd. 9, 
Aarhus C, DK 

Overview

Troels Herlin practices practicing medicine in Aarhus C, Denmark.

Herlin is highly rated in 13 conditions, according to our data. Their clinical expertise encompasses Juvenile Idiopathic Arthritis (JIA), Arthritis, Osteomyelitis, Chronic Recurrent Multifocal Osteomyelitis, and Osteotomy.

They are actively involved in clinical research, co-authoring 136 peer reviewed articles and participating in 2 clinical trials.

Locations

Vennelyst Blvd. 9, Aarhus C, 8000, Denmark
Other Locations
Palle Juul Jensens Blvd. 99, Aarhus N, 8200, Denmark

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3 Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients From 1 Year to <18 Years of Age With Juvenile Idiopathic Arthritis (JIA)
A Phase 3 Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients From 1 Year to <18 Years of Age With Juvenile Idiopathic Arthritis (JIA)
Enrollment Status: Recruiting
Publish Date: May 12, 2026
Intervention Type: Drug
Study Drug: Baricitnib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Withdrawal, Safety and Efficacy Study of Oral Baricitinib in Patients From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic Arthritis (JIA)
A Randomized, Double-Blind, Placebo-Controlled, Withdrawal, Safety and Efficacy Study of Oral Baricitinib in Patients From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic Arthritis (JIA)
Enrollment Status: Completed
Publish Date: October 07, 2022
Intervention Type: Drug
Study Drug: Baricitnib
Study Phase: Phase 3
View 1 Less Clinical Trial

136 Total Publications

The role of Janus kinase inhibitors in the treatment of juvenile idiopathic arthritis
The role of Janus kinase inhibitors in the treatment of juvenile idiopathic arthritis
Journal: Ugeskrift for laeger
Published: August 19, 2025

Frequently Asked Questions about Troels Herlin

Is Troels Herlin a top-rated expert for Juvenile Idiopathic Arthritis (JIA)?

MediFind is an objective health platform that identifies experts based on real-world data. Troels Herlin is classified as an Elite expert for Juvenile Idiopathic Arthritis (JIA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Troels Herlin participate in research or clinical trials?

Yes. Troels Herlin has published 136 articles and abstracts on conditions like Juvenile Idiopathic Arthritis (JIA). You can view a list of Troels Herlin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Herlin's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 19 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile